Post-transplant lymphoproliferative disorders (PTLD) following solid organ transplantation: The role of combination chemotherapy.

被引：0
|
作者：
Cullis, JO
McCarthy, M
Heaton, N
Williams, R
JanMohamed, R
Pagliuca, A
Mufti, GJ
机构：
[1] UNIV LONDON KINGS COLL HOSP,DEPT HAEMATOL MED,LONDON,ENGLAND
[2] UNIV LONDON KINGS COLL HOSP,INST LIVER STUDIES,LONDON,ENGLAND
来源：
BLOOD | 1996年 / 88卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：359 / 359
页数：1
相关论文
共 50 条
  • [31] POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS FOLLOWING ALEMTUZUMAB INDUCTION IN KIDNEY TRANSPLANTATION
    Sawhney, Harpreet
    Charif, Rawya
    Galliford, Jack
    McLean, Adam
    Taube, David
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2015, 30
  • [32] POST-TRANSPLANT LYMPHOPROLIFERATIVE DISEASE AND LYMPHOMA [PTLD] AFTER LIVER TRANSPLANTATION
    Daniel, Anderson
    Jonathon, Fawcett
    Anthony, Griffin
    Glenda, Balderson
    IMMUNOLOGY AND CELL BIOLOGY, 2011, 89 (07): : A44 - A44
  • [33] Post-transplant lymphoproliferative disease (PTLD): lymphokine production and PTLD
    Tosato, G
    Teruya-Feldstein, J
    Setsuda, J
    Pike, SE
    Jones, KD
    Jaffe, ES
    SPRINGER SEMINARS IN IMMUNOPATHOLOGY, 1998, 20 (3-4): : 405 - 423
  • [34] Post-transplant lymphoproliferative disorders in children: The role of chemotherapy in the era of rituximab
    Gallego, S.
    Llort, A.
    Gros, L.
    Sanchez de Toledo, J., Jr.
    Bueno, J.
    Moreno, A.
    Nieto, J.
    Sanchez de Toledo, J.
    PEDIATRIC TRANSPLANTATION, 2010, 14 (01) : 61 - 66
  • [35] Post-transplant lymphoproliferative disease (PTLD): lymphokine production and PTLD
    Giovanna Tosato
    Julie Teruya-Feldstein
    Joyce Setsuda
    Sandra E. Pike
    Karen D. Jones
    Elaine S. Jaffe
    Springer Seminars in Immunopathology, 1998, 20 : 405 - 423
  • [36] Risk Factors for Post-Transplant Lymphoproliferative Disorder (PTLD) and Its Impact on Patient Survival in Solid Organ Transplantation in the United States
    Cho, Y. W.
    Sampaio, M. S.
    Hutchinson, I. V.
    Qazi, Y.
    Shah, T.
    Fong, T. -L.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 : 510 - 511
  • [37] Identification of high-risk monomorphic post-transplant lymphoproliferative disorder following solid organ transplantation
    Voorhees, Timothy J.
    Kannan, Kavya K.
    Galeotti, Jonathan
    Grover, Natalie
    Vaidya, Rakhee
    Moore, Dominic T.
    Montgomery, Nathan D.
    Beaven, Anne W.
    Dittus, Christopher
    LEUKEMIA & LYMPHOMA, 2021, 62 (01) : 86 - 94
  • [38] Clinicopathologic Features of Patients with Post-Transplant Lymphoproliferative Disorder (PTLD) Following Hematopoietic Stem Cell Transplant (HSCT) Are Different from PTLD in Solid organ Recipients (SOT)
    Zhou, J.
    Van Besien, K.
    Orazi, A.
    Cesarman, E.
    Knowles, D. M.
    Geyer, J. T.
    LABORATORY INVESTIGATION, 2014, 94 : 390A - 390A
  • [39] Clinicopathologic Features of Patients with Post-Transplant Lymphoproliferative Disorder (PTLD) Following Hematopoietic Stem Cell Transplant (HSCT) Are Different from PTLD in Solid organ Recipients (SOT)
    Zhou, J.
    Van Besien, K.
    Orazi, A.
    Cesarman, E.
    Knowles, D. M.
    Geyer, J. T.
    MODERN PATHOLOGY, 2014, 27 : 390A - 390A
  • [40] Comparative study of post-transplant lymphoproliferative disorders after solid organ transplantation versus hematopoietic stem cell transplantation
    Romero, S.
    Montoro, J.
    Sanz, J.
    Guinot, M.
    Balaguer, A.
    Iacoboni, G.
    Mayordomo, E.
    Lopez-Andujar, R.
    Beneyto, I.
    Almenar, L.
    Sole, A.
    Sanz, G.
    Sanz, M. A.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S426 - S426
12345